4//SEC Filing
Echerd Margaret 4
Accession 0001437749-21-022057
CIK 0000072444other
Filed
Sep 12, 8:00 PM ET
Accepted
Sep 13, 7:29 PM ET
Size
12.0 KB
Accession
0001437749-21-022057
Insider Transaction Report
Form 4
Vaxart, Inc.VXRT
Echerd Margaret
VP, Corporate Controller, PAO
Transactions
- Exercise/Conversion
Common Stock
2021-09-10$5.17/sh+334$1,727→ 334 total - Exercise/Conversion
Stock Option (Right to Buy)
2021-09-10−334→ 2,333 totalExercise: $5.17Exp: 2028-05-24→ Common Stock (334 underlying) - Exercise/Conversion
Common Stock
2021-09-10$0.77/sh+1,467$1,130→ 1,801 total - Sale
Common Stock
2021-09-10$9.10/sh−1,801$16,389→ 0 total - Exercise/Conversion
Stock Option (Right to Buy)
2021-09-10−1,467→ 29,352 totalExercise: $0.77Exp: 2029-06-11→ Common Stock (1,467 underlying)
Footnotes (3)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 1, 2021.
- [F2]The stock option vests over a four-year period, with 25% of the shares subject to the stock option vesting on the first anniversary of the vesting commencement date of April 9, 2018, and the remaining shares in 36 equal monthly installments thereafter.
- [F3]The stock option vests over a four-year period, with 25% of the shares subject to the stock option vesting on the first anniversary of the vesting commencement date of May 10, 2019, and the remaining shares in 36 equal monthly installments thereafter.
Documents
Issuer
Vaxart, Inc.
CIK 0000072444
Entity typeother
Related Parties
1- filerCIK 0001530193
Filing Metadata
- Form type
- 4
- Filed
- Sep 12, 8:00 PM ET
- Accepted
- Sep 13, 7:29 PM ET
- Size
- 12.0 KB